ANGELA PARETTI: Open Payments
NPI 1124686571 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 63 payments from 17 companies in 2025. Trend: 2023 $989 · 2024 $1,041 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $296 |
| ABBVIE INC. | 11 | $164 |
| Axsome Therapeutics, Inc. | 10 | $159 |
| Lundbeck LLC | 6 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Gilead Sciences, Inc. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 1 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: DOVATO, Auvelity, REXULTI, VRAYLAR, FANAPT, PIFELTRO, INGREZZA, CABENUVA.
Industry payments across LA — which companies pay providers there.
